Evaluating HbA1c as a Prognostic Indicator in COVID-19 Patients
DOI:
https://doi.org/10.48047/Keywords:
Keywords: COVID-19, Diabetes mellitus, Glycated hemoglobin, HbA1c, Hypertension, InflammationAbstract
Background: Diabetes mellitus has been widely recognized as a significant risk factor influencingthe prognosis of COVID-19, with patients exhibiting poorer outcomes and higher mortality rates. However, the role of pre-COVID-19 glycemic control in determining the severity of the disease and clinical outcomes remains a subject of ongoing investigation.
Downloads
							Download data is not yet available.
						
					Downloads
Published
																			2025-02-19
																	
				Issue
Section
								Articles
							
						 
						



 
  
  
  
  
 
